Folds and Curves Mo Kashkoush

Adam Ryason, PhD is the Founder and CEO of Intelligent Medicine, a medical modeling and simulation startup company. Adam and his team created Circulate software to help medical and other facilities design shared spaces that minimize infection transmission. We discuss the basic science of how disease spreads, as well as how Adam and Intelligent Medicine are helping us all get back to normal, safely.

You can learn more about Adam and Intelligent Medicine at these links:


Intelligent Medicine: https://www.intmed.us/
Adam Ryason, PhD: https://www.linkedin.com/in/adam-ryason-phd-5617a7180/

For more Folds & Curves, check out: https://www.foldsandcurves.com/

Sam Bott, PharmD was one of the first people who got me interested in biotech. He currently works as a Medical Outcomes Liaision in the biopharmaceutical industry, has previously worked as a consultant in Market Access Strategy at IQVIA, and is a cofounder of the University of Pittsburgh's Biotech Investment Fantasy League and Pittsburgh Pharmacy Investment Portfolio. On this episode, he share's a breadth of insights into the concepts of market access and patient access.  Sam's opinions are his own and do not reflect the views of Akebia Therapeutics.

For more information about Sam and the Pittsburgh Pharmacy Investment Portfolio, check out:


LinkedIn: https://www.linkedin.com/in/samuel-bo...
PPIP: https://www.pharmacyportfolio.com/

For more Folds & Curves, please visit: https://www.foldsandcurves.com/ 

Vaughn Cooper, PhD is an evolutionary biologist, microbiologist, and Professor of Microbiology and Molecular Genetics, and Computational and Systems Biology at the University of Pittsburgh School of Medicine. He has co-founded and is Director of the Center for Evolutionary Biology and Medicine, founded and directs the Microbial Genomics Sequencing (MiGS) Center, and is the Chair of the Council for Microbial Sciences for the American Society of Microbiology. During the COVID-19 pandemic, he's used his expertise to help track and control outbreaks in partnership with the Louisiana Department of Health and Louisiana State University. 

On this episode, we discuss some of the evolutionary biology concepts that apply to SARS-CoV-2 variants, as well as EvolvingSTEM, an initiative that Vaughn is passionate about which engages high schools students with topics in evolution and heredity by conducting a weeklong experiment with bacteria.

To learn more about Vaughn, MiGS, EvolvingSTEM, and The Cooper Lab, check out these links:


Twitter: https://twitter.com/vscooper
Cooper Lab site: http://micropopbio.org/
EvolvingSTEM site: https://evolvingstem.org/
MiGS site: https://www.migscenter.com/
YouTube (great SARS-CoV-2 videos!): https://www.youtube.com/user/vscooper

For more Folds & Curves, check out: https://www.foldsandcurves.com/

Alex Connor is a PhD student in Chemical and Biological Engineering at Rensselaer Polytechnic Institute, focusing on leveraging the useful properties of silk-mimetic polymers for a whole range of applications. Alex knows a ton about protein engineering and synthetic biology, and is using his knowledge as a cofounder of Ripely to create biologically-inspired solutions for food preservation, insecurity, and waste. This episode was a great primer on synthetic biology, but we also specifically discuss some of Alex’s work with biomaterials.

Follow Alex on LinkedIn to learn more about him and his progress at Ripely! For more Folds & Curves, visit: https://www.foldsandcurves.com/

Erin McCreary, PharmD, BCPS, BCIDP, is an infectious disease pharmacist and clinical assistant professor who is a leader on COVID-19 therapeutics. She has contributed to COVID-19 efforts as a clinician, evaluator of constantly-evolving clinical evidence, and communicator of findings. In our discussion, we discuss COVID-19 therapeutics and Erin's experience during the pandemic. All information discussed in this episode is current as of 2/10/2021.
To learn more about Erin and to stay up to date, you can follow her on Twitter at https://twitter.com/ErinMcCreary​
You can also hear more from Erin through the Society of Infectious Disease Pharmacists Breakpoints podcast: https://sidp.org/podcasts​
To learn more about Folds and Curves, visit https://www.foldsandcurves.com/

I am so grateful to have met Stefanos Koutsoukos on Clubhouse, where we were able to extend our relationship beyond. He shares incredible perspectives on rare disease as a patient, scientist, and advocate. I think that this episode of Folds & Curves tells a comprehensive story, covering topics like:


the diagnostic odyssey: what it's like for rare disease patients and families to reach a diagnosis,
patient rights surrounding their genetic data,
the genetics and biochemistry of ASPRV1-mediated ichthyosis, and
gene therapy approaches to rare disease

I hope that you all enjoy 🙂 . Please check out this incredible Medium post written by Stefanos describing his diagnostic odyssey: https://medium.com/@stefanoskoutsoukos/finding-ithaca-after-our-98-year-diagnostic-odyssey-7b249dad375d